Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
23 January 2014Website:
http://www.mymd.comNext earnings report:
14 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Wed, 03 Jul 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
MYMD Latest News
BALTIMORE--(BUSINESS WIRE)---- $MYMD--MyMD Pharmaceuticals, Inc. (Nasdaq: MYMD) (“MyMD” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for age-related diseases and autoimmune and inflammatory conditions, today announced the appointment of Mitchell Glass, M.D., a member of the board of directors of the Company, as president and chief medical officer. The Company also announced the appointment of Mr. Stephen Friscia, a veteran investor, to the board of.
What type of business is MyMD Pharmaceuticals?
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines; and to delay aging and increase longevity, as well as treat autoimmune diseases and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic derivative of cannabidiol for treating chronic pain, addiction, and epilepsy. The company was founded in 2014 and is headquartered in Baltimore, Maryland.
What sector is MyMD Pharmaceuticals in?
MyMD Pharmaceuticals is in the Healthcare sector
What industry is MyMD Pharmaceuticals in?
MyMD Pharmaceuticals is in the Biotechnology industry
What country is MyMD Pharmaceuticals from?
MyMD Pharmaceuticals is headquartered in United States
When did MyMD Pharmaceuticals go public?
MyMD Pharmaceuticals initial public offering (IPO) was on 23 January 2014
What is MyMD Pharmaceuticals website?
https://www.mymd.com
Is MyMD Pharmaceuticals in the S&P 500?
No, MyMD Pharmaceuticals is not included in the S&P 500 index
Is MyMD Pharmaceuticals in the NASDAQ 100?
No, MyMD Pharmaceuticals is not included in the NASDAQ 100 index
Is MyMD Pharmaceuticals in the Dow Jones?
No, MyMD Pharmaceuticals is not included in the Dow Jones index
When does MyMD Pharmaceuticals report earnings?
The next expected earnings date for MyMD Pharmaceuticals is 14 August 2024